Semisynthetic pentacyclic triterpenoids in the cancer setting: Ursolic acid and its derivatives

Pentacyclic Triterpenes as Promising Agents in Cancer

Volumn , Issue , 2011, Pages 249-276

  Salvador, Jorge A R ^a,b   Moreira, Vânia M ^a,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b INSTITUTO PEDRO NUNES   (Portugal)

^c UNIVERSIDADE LUSÓFONA DE HUMANIDADES E TECNOLOGIAS   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892078844     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (71)

1. Clardy, J.; Walsh, C., Lessons from natural molecules. Nature, 2004, 432, 829-837.
2. Gershenzon, J.; Dudareva, N., The function of terpene natural products in the natural world. Nat. Chem. Biol., 2007, 3, 408-414.
3. Dzubak, P.; Hajduch, M.; Vydra, D.; Hustova, A.; Kvasnica, M.; Biedermann, D.; Markova, L.; Urban, M.; Sarek, J., Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat. Prod. Rep., 2006, 23, 394-411.
4. Liu, J., Oleanolic and ursolic acid: research perspectives. J. Ethnopharmacol., 2005, 100, 92-94.
5. Aggarwal, B. B.; Shishodia, S., Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol., 2006, 71, 1397-1421.
6. Liu, J., Pharmacology of oleanolic and ursolic acid. J. Ethnopharmacol., 1995, 49, 57-68.
7. Baglin, I.; Mitaine-Offer, A. C.; Nour, M.; Tan, K.; Cavé, C.; Lacaille-Dubois, M. A., A review of natural and modified betulinic, ursolic and echinocystic acid derivatives as potential antitumor and anti-HIV agents. Mini Rev. Med. Chem., 2003, 3, 525-539.
8. Ovesna, Z.; Vachalkova, A.; Horvathova, K.; Tothova, D., Pentacyclic triterpenoic acids: new chemoprotective compounds. Neoplasma, 2004, 51, 327-333.
9. Essaady, D.; Najid, A.; Simon, A.; Denizot, Y.; Chulia, A. J.; Delage, C., Effects of Ursolic Acid and Its Analogs on Soybean 15-Lipoxygenase Activity and the Proliferation Rate of a Human Gastric Tumor-Cell Line. Mediators Inflamm., 1994, 3, 181-184.
10. Mizushina, Y.; Iida, A.; Ohta, K.; Sugawara, F.; Sakaguchi, K., Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase. Biochem J., 2000, 350, 757-763.
11. Chiang, Y. M.; Chang, J. Y.; Kuo, C. C.; Chang, C. Y.; Kuo, Y. H., Cytotoxic triterpenes from the aerial roots of Ficus microcarpa. Phytochemistry, 2005, 66, 495-501.
12. Lee, I.; Lee, J.; Lee, Y. H.; Leonard, J., Ursolic acid-induced changes in tumor growth, O2 consumption, and tumor interstitial fluid pressure. Anticancer Res., 2001, 21, 2827-2833.
13. Kim, D. K.; Baek, J. H.; Kang, C. M.; Yoo, M. A.; Sung, J. W.; Kim, D. K.; Chung, H. Y.; Kim, N. D.; Choi, Y. H.; Lee, S. H.; Kim, K. W., Apoptotic activity of ursolic acid may correlate with the inhibition of initiation of DNA replication. Int. J. Cancer, 2000, 87, 629-636.
14. Satomi, Y.; Nishino, H.; Shibata, S., Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2. Anticancer Res., 2005, 25, 4043-4047.
15. Tang, C.; Lu, Y. H.; Xie, J. H.; Wang, F.; Zou, J. N.; Yang, J. S.; Xing, Y. Y.; Xi, T., Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis. Anti-Cancer Drugs, 2009, 20, 249-258.
16. Ramos, A. A.; Lima, C. F.; Pereira, M. L.; Fernandes-Ferreira, M.; Pereira-Wilson, C., Antigenotoxic effects of quercetin, rutin and ursolic acid on HepG2 cells: Evaluation by the comet assay. Toxicol. Lett., 2008, 177, 66-73.
17. Zhang, D. M.; Tang, P. M. K.; Chan, J. Y. W.; Lam, H. M.; Au, S. W. N.; Kong, S. K.; Tsui, S. K. W.; Waye, M. M. Y.; Mak, T. C. W.; Fung, K. P., Anti-proliferative effect of ursolic acid on multidrug, resistant hepatoma cells R-HepG2 by apoptosis induction. Cancer Biol. Ther., 2007, 6, 1381-1389.
18. Rios, M. Y.; Gonzalez-Morales, A.; Villarreal, M. L., Sterols, triterpenes and biflavonoids of Viburnum jucundum and cytotoxic activity of ursolic acid. Planta Med., 2001, 67, 683-684.
19. Li, J.; Guo, W. J.; Yang, Q. Y., Effects of ursolic acid and oleanolic acid on human colon carcinoma cell line HCT15. World J. Gastroenterol., 2002, 8, 493-495.
20. Harmand, P. O.; Duval, R.; Delage, C.; Simon, A., Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells. Int. J. Cancer, 2005, 114, 1-11.
21. Harmand, P. O.; Duval, R.; Liagre, B.; Jayat-Vignoles, C.; Beneytout, J. L.; Delage, C.; Simon, A., Ursolic acid induces apoptosis through caspase-3 activation and cell cycle arrest in HaCat cells. Int. J. Oncol., 2003, 23, 105-112.
22. Cipak, L.; Grausova, L.; Miadokova, E.; Novotny, L.; Rauko, P., Dual activity of triterpenoids: apoptotic versus antidifferentiation effects. Archiv. Toxicol., 2006, 80, 429-435.
23. Andersson, D.; Liu, J. J.; Nilsson, A.; Duan, R. D., Ursolic acid inhibits proliferation and stimulates apoptosis in HT29 cells following activation of alkaline sphingomyelinase. Anticancer Res., 2003, 23, 3317-3322 and references cited therein.
24. Baglin, I.; Poumaroux, A.; Nour, M.; Tan, K.; Mitaine-Offer, A. C.; Lacaille-Dubois, M. A.; Chauffert, B.; Cavé, C., New ursolic and betulinic berivatives as potential cytotoxic agents. J. Enz. Inhib. Med. Chem., 2003, 18, 111-117.
25. Andersson, D.; Nilsson, A.; Duan, R. D., Ursolic acid and other pentacyclic triterpenoids stimulate intestinal alkaline sphingomyelinase in vitro. Eur. J. Lipid Sci. Technol., 2006, 108, 103-108.
26. Lai, M. Y.; Leung, H. W. C.; Yang, W. H.; Chen, W. H.; Lee, H. Z., Up-regulation of matrix metalloproteinase family gene involvement in ursolic acid-induced human lung non-small carcinoma cell apoptosis. Anticancer Res., 2007, 27, 145-153 and references cited therein.
27. Cardenas, C.; Quesada, A. R.; Medina, M. A., Effects of ursolic acid on different steps of the angiogenic process. Biochem. Biophys. Res. Commun., 2004, 320, 402-408.
28. Weinberg, R. A., The Biology of Cancer. New York: Garland Science; 2007.
29. Cha, H. J.; Bae, S. K.; Lee, H. Y.; Lee, O. H.; Sato, H.; Seiki, M.; Park, B. C.; Kim, K. W., Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res., 1996, 56, 2281-2284.
30. Shishodia, S.; Majumdar, S.; Banerjee, S.; Aggarwal, B. B., Ursolic acid inhibits nuclear factor-kB activation induced by carcinogenic agents through suppression of IkBa kinase and p65 phosphorylation: correlation with downregulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res., 2003, 63, 4375-4383.
31. Cha, H. J.; Park, M. T.; Chung, H. Y.; Kim, N. D.; Sato, H.; Seiki, M.; Kim, K. W., Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells. Oncogene, 1998, 16, 771-778.
32. Sohn, K. H.; Lee, H. Y.; Chung, H. Y.; Young, H. S.; Yi, S. Y.; Kim, K. W., Anti-angiogenic activity of triterpene acids. Cancer Lett., 1995, 94, 213-218.
33. Chen, Y. H.; Chang, F. R.; Wu, C. C.; Yen, M. H.; Liaw, C. C.; Huang, H. C.; Kuo, Y. H.; Wu, Y. C., New cytotoxic 6-oxygenated 8,9-dihydrofurocoumarins, hedyotiscone A-C, from Hedyotis biflora. Planta Med., 2006, 72, 75-78.
34. Hsu, Y. L.; Kuo, P. L.; Lin, C. C., Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells. Life Sci., 2004, 75, 2303-2316.
35. Essaady, D.; Simon, A.; Ollier, M.; Maurizis, J. C.; Chulia, A. J.; Delage, C., Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrest. Cancer Lett., 1996, 106, 193-197.
36. Manu, K. A.; Kuttan, G., Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF-kB mediated activation of bcl-2 in B16F-10 melanoma cells. Int. Immunopharmacol., 2008, 8, 974-981.
37. Lee, H. Y.; Chung, H. Y.; Kim, K. H.; Lee, J. J.; Kim, K. W., Induction of differentiation in the cultured F9 teratocarcinoma stem cells by triterpene acids. J. Cancer Res. Clin. Oncol., 1994, 120, 513-518.
38. Hollosy, F.; Idei, M.; Csorba, G.; Szabo, E.; Bokonyi, G.; Seprodi, A.; Meszaros, G.; Szende, B.; Keri, G., Activation of caspase-3 protease during the process of ursolic acid and its derivative-induced apoptosis. Anticancer Res., 2001, 21, 3485-3492.
39. Bonaccorsi, I.; Altieri, F.; Sciamanna, I.; Oricchio, E.; Grillo, C.; Contartese, G.; Galati, E. M., Endogenous reverse transcriptase as a mediator of ursolic acid's anti-proliferative and differentiating effects in human cancer cell lines. Cancer Lett., 2008, 263, 130-139 and references cited therein.
40. Duval, R. E.; Harmand, P. O.; Jayat-Vignoles, C.; Cook-Moreau, J.; Pinon, A.; Delage, C.; Simon, A., Differential involvement of mitochondria during ursolic acid-induced apoptotic process in HaCat and M4Beu cells. Oncol. Rep., 2008, 19, 145-149.
41. Gnoatto, S. C. B.; Dassonville-Klimpt, A.; Da Nascimento, S.; Galera, P.; Boumediene, K.; Gosmann, G.; Sonnet, P.; Moslemi, S., Evaluation of ursolic acid isolated from Ilex paraguariensis and derivatives on aromatase inhibition. Eur. J. Med. Chem., 2008, 43, 1865-1877.
42. Ringbom, T.; Segura, L.; Noreen, Y.; Perera, P.; Bohlin, L., Ursolic acid from Plantago major, a selective inhibitor of cyclooxygenase-2 catalyzed prostaglandin biosynthesis. J. Nat. Prod., 1998, 61, 1212-1215.
43. Najid, A.; Simon, A.; Cook, J.; Chable-Ravinovitch, H.; Delage, C.; Chulia, A. J.; Rigaud, M., Characterization of ursolic acid as a lipoxygenase and cyclooxigenase inhibitor using macrophages, platelets and differentiated HL60 leukemic cells. FEBS, 1992, 299, 213-217.
44. Suh, N.; Honda, T.; Finlay, H. J.; Barchowsky, A.; Williams, C.; Benoit, N. E.; Xie, Q. W.; Nathan, C.; Gribble, G. W.; Sporn, M. B., Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res., 1998, 58, 717-723 and references cited therein.
45. Subbaramaiah, K.; Michaluart, P.; Sporn, M. B.; Dannenberg, A. J., Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res., 2000, 60, 2399-2404.
46. Achiwa, Y.; Hasegawa, K.; Udagawa, Y., Regulation of the phosphatidylinositol 3-Kinase-Akt and the mitogen-activated protein kinase pathways by ursolic acid in human endometrial cancer cells. Biosci. Biotech. Biochem., 2007, 71, 31-37.
47. Yim, E. K.; Lee, K. H.; Namkoong, S. E.; Um, S. J.; Park, J. S., Proteomic analysis of ursolic acid-induced apoptosis in cervical carcinoma cells. Cancer Lett., 2006, 235, 209-220.
48. Kassi, E.; Papoutsi, Z.; Pratsinis, H.; Aligiannis, N.; Manoussakis, M.; Moutsatsou, P., Ursolic acid, a naturally occurring triterpenoid, demonstrates anticancer activity on human prostate cancer cells. J. Cancer Res. Clin. Oncol., 2007, 133, 493-500.
49. Pathak, A. K.; Bhutani, M.; Nair, A. S.; Ahn, K. S.; Chakraborty, A.; Kadara, H.; Guha, S.; Sethi, G.; Aggarwal, B. B., Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells. Mol. Cancer Res., 2007, 5, 943-955.
50. You, H. J.; Choi, C. Y.; Kim, J. Y.; Park, S. J.; Hahm, K. S.; Jeong, H. G., Ursolic acid enhances nitric oxide and tumor necrosis factor a production via nuclear factor-kB activation in the resting macrophages. FEBS Lett., 2001, 509, 156-160.
51. Ikeda, Y.; Murakami, A.; Ohigashi, H., Ursolic acid promotes the release of macrophage migration inhibitory factor via ERK2 activation in resting mouse macrophages. Biochem. Pharmacol., 2005, 70, 1497-1505.
52. Liu, X. S.; Jiang, J. K., Induction of apoptosis and regulation of the MAPK pathway by ursolic acid in human leukemia K562 cells. Planta Med., 2007, 73, 1192-1194.
53. Simon, A.; Najid, A.; Chulia, A. J.; Delage, C.; Rigaud, M., Inhibition of lipoxygenase activity and HL-60 leukemic cell proliferation by ursolic acid isolated from heather flowers (Calluna vulgaris). Biochim. Biophys. Acta, 1992, 1125, 68-72.
54. Ma, C.-M.; Cai, S.-Q.; Cui, J.-R.; Wang, R.-Q.; Tu, P.-F.; Hatorri, M.; Daneshtalab, M., The cytotoxic activity of ursolic acid derivatives. Eur. J. Med. Chem., 2005, 40, 582-589.
55. Ramachandran, S.; Prasad, N. R., Effect of ursolic acid, a triterpenoid antioxidant, on ultraviolet-B radiation-induced cytotoxicity, lipid peroxidation and DNA damage in human lymphocytes. Chem. Biol. Inter., 2008, 176, 99-107.
56. Baek, J. H.; Lee, Y. S.; Kang, C. M.; Kim, J. A.; Kwon, K. S.; Son, H. C.; Kim, K. W., Intracellular Ca2+ release mediates ursolic acid-induced apoptosis in human leukemic HL-60 cells. Int. J. Cancer, 1997, 73, 725-728.
57. Lauthier, F.; Taillet, L.; Trouillas, P.; delage, C.; Simon, A., Ursolic acid triggers calcium-dependent apoptosis in human Daudi cells. Anti-Cancer Drugs, 2000, 11, 737-745.
58. Ohigashi, H.; Takamura, H.; Koshimizu, K.; Tokuda, H.; Ito, Y., Search for possible antitumor promoters by inhibition of 12-O-tetradecanoylphorbol-13-acetate-induces Epstein-Barr virus activation; ursolic acid and oleanolic acid from an anti-inflammatory chinese medicinal plant, Glechoma Hederaceae L. Cancer Lett., 1986, 30, 143-151.
59. Guo-qing, C.; Yi, S.; Hong, D., Anti-tumor effect and its mechanisms of ursolic acid on human esophageal carcinoma cell Eca-109 in vivo. Chin J. Cancer Res., 2008, 20, 205-210.
60. Andersson, D.; Cheng, Y. J.; Duan, R. D., Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats. J. Cancer Res. Clin. Oncol., 2008, 134, 101-107 and references cited therein.
61. Tokuda, H.; Ohigashi, H.; Koshimizu, K.; Ito, Y., Inhibitory effects of ursolic acid and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Lett., 1986, 33, 279-285.
62. Ikeda, Y.; Murakami, A.; Nishizawa, T.; Ohigashi, H., Uroslic acid enhances cyclooxygenase and tumor necrosis factor-a expression in mouse skin. Biosci. Biotech. Biochem., 2006, 70, 1033-1037.
63. Hsu, H. Y.; Yang, J. J.; Lin, C. C., Effects of oleanolic acid and ursolic acid on inhibiting tumor growth and enhancing the recovery of hematopoietic system postirradiation in mice. Cancer Lett., 1997, 111, 7-13.
64. Raphael, T. J.; Kuttan, G., Effect of naturally occurring triterpenoids ursolic acid and glycyrrhizic acid on the cell-mediated immune responses of metastatic tumor-bearing animals. Immunopharmacol. Immunotoxicol., 2008, 30, 243-255.
65. Honda, T.; Finlay, H. J.; Gribble, G. W.; Suh, N.; Sporn, M. B., New enone derivatives of oleanolic and ursolic acid as inhibitors of nitric oxide production in mouse macrophages. Bioorg. Med. Chem. Lett., 1997, 7, 1623-1628.
66. Honda, T.; Gribble, G. W.; Suh, N.; Finlay, H. J.; Rounds, B. V.; Bore, L.; Favaloro, F. G.; Wang, Y. P.; Sporn, M. B., Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages. J. Med. Chem., 2000, 43, 1866-1877.
67. Honda, T.; Rounds, B. V.; Bore, L.; Finlay, H. J.; Favaloro, F. G.; Suh, N.; Wang, Y. P.; Sporn, M. B.; Gribble, G. W., Synthetic oleanane and ursane triterpenoids with modified rings A and C: A series of highly active inhibitors of nitric oxide production in mouse macrophages. J. Med. Chem., 2000, 43, 4233-4246.
68. Chadalapaka, G.; Jutooru, I.; McAlees, A.; Stefanac, T.; Safe, S., Structure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives. Bioorg. Med. Chem Lett., 2008, 18, 2633-2639.
69. Meng, Y.-Q.; Liu, D.; Cai, L.-L.; Chen, H.; Cao, B.; Wang, Y.-Z., The synthesis of ursolic acid derivatives with cytotoxic activity and the investigation of their preliminary mechanism of action. Bioorg. Med. Chem., 2009, 17, 848-854.
70. Deng, S. L.; Baglin, I.; Nour, M.; Cave, C., Synthesis of phosphonodipeptide conjugates of ursolic acid and their homologs. Heteroatom. Chem., 2008, 19, 55-65.
71. Korovin, A. V.; Tkachev, A. V., Synthesis of quinoxalines fused with triterpenes, ursolic acid and betulin derivatives. Russ. Chem. Bull. Int. Ed., 2001, 50, 304-310.